search
Back to results

Stress-Echography in Hereditary Haemorrhagic Telangiectasia Patient With Hepatic Involvement (ROSE)

Primary Purpose

Hereditary Hemorrhagic Telangiectasia, Rendu Osler Disease

Status
Recruiting
Phase
Not Applicable
Locations
France
Study Type
Interventional
Intervention
Stress echocardiography
Sponsored by
Hospices Civils de Lyon
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional diagnostic trial for Hereditary Hemorrhagic Telangiectasia focused on measuring HHT, Stress echography, Pulmonary arterial pressures

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria: HHT patient > 18 yo Hepatic involvement (hepatic artery diameter > 6mm) Patient having received the information and signed the informed consent form Patient affiliated to a social security scheme or beneficiaries of a similar scheme Exclusion Criteria: Haemoglobin < 90 g/L Active Infection Atrial Fibrillation permanent or persistent Known cardiopathy Pregnant or breastfeeding woman (by questioning) Adult subject to a legal protection measure (guardianship) Participation in another clinical trial that may interfere with the proposed trial (investigator judgment) Patient physically unable to pedal Patient with Pulmonary arteriovenous malformations awaiting embolization Patient treated with beta-blockers Secondary Exclusion Criteria verified on rest ultrasound PAH (Pulmonary Arterial Hypertension) at rest (Vmax > 2.8 m/sec) Inability to obtain a stream of IT at rest Patient with atrial fibrillation (AF)

Sites / Locations

  • Service Explorations fonctionnelles cardiovasculaires - Hôpital Louis PradelRecruiting
  • Service génétique - Hôpital Femme Mère EnfantRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Other

Other

Arm Label

HHT patients with hepatic involvement and high cardiac index

HHT patients with hepatic involvement and normal cardiac index

Arm Description

HHT patients with a dilated (diameter > 6mm) or tortuous hepatic artery and an elevated cardiac index (> 3.5 l/mn/m²)

HHT patients with a dilated or tortuous hepatic artery and a normal cardiac index

Outcomes

Primary Outcome Measures

Comparison of exercise pulmonary artery systolic pressure in patients with HHT and liver involvement.
The systolic pulmonary artery pressure (PAPS) during exercise will be compared between the two groups of patients. PAPS will be estimated by the maximum velocity (Vmax) of tricuspid insufficiency flow at peak exercise on cardiac ultrasound.

Secondary Outcome Measures

Full Information

First Posted
July 13, 2023
Last Updated
August 17, 2023
Sponsor
Hospices Civils de Lyon
search

1. Study Identification

Unique Protocol Identification Number
NCT05954481
Brief Title
Stress-Echography in Hereditary Haemorrhagic Telangiectasia Patient With Hepatic Involvement
Acronym
ROSE
Official Title
Evaluation of the Value of Measuring Pulmonary Arterial Pressures During Exercise in Hereditary Haemorrhagic Telangiectasia Patients With Hepatic Involvement - Pilot Study
Study Type
Interventional

2. Study Status

Record Verification Date
August 2023
Overall Recruitment Status
Recruiting
Study Start Date
August 3, 2023 (Actual)
Primary Completion Date
August 2024 (Anticipated)
Study Completion Date
August 2024 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Hospices Civils de Lyon

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
The hepatic involvement of HHT (Hereditary Haemorrhagic Telangiectasia) disease is characterised by the formation of arterio-sus-hepatic shunts which lead to dilatation of the hepatic artery and may result in high output heart failure. This evolves silently for long-standing period from left ventricular cavities dilatation to advanced heart failure with post-capillary pulmonary hypertension (PH) (more rarely pre-capillary), and its evolution is poorly understood. The specific treatment options for HHT disease are either the use of anti-angiogenic therapy (bevacizumab) or liver transplantation. As rest echocardiography can only detect advanced cases or heart failure with rest PH, the investigators speculate that exercise echocardiography can provide additional information in patients without rest PH. The hypothesis is that an exaggerated pulmonary pressure increase during exercise may precede the occurrence of rest PH in the course of the disease. It could identify patients with substantial heart failure at an earlier stage and may facilitate the access to liver transplantation. These parameters have never been studied in this context and it seems interesting to evaluate them in this pilot study. The investigators hypothesise that HHT (Hereditary Haemorrhagic Telangiectasia) patients with hepatic involvement and cardiac high output will have significantly greater and/or earlier elevation of exercise pulmonary arterial pressures than those with normal cardiac output.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Hereditary Hemorrhagic Telangiectasia, Rendu Osler Disease
Keywords
HHT, Stress echography, Pulmonary arterial pressures

7. Study Design

Primary Purpose
Diagnostic
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Non-Randomized
Enrollment
40 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
HHT patients with hepatic involvement and high cardiac index
Arm Type
Other
Arm Description
HHT patients with a dilated (diameter > 6mm) or tortuous hepatic artery and an elevated cardiac index (> 3.5 l/mn/m²)
Arm Title
HHT patients with hepatic involvement and normal cardiac index
Arm Type
Other
Arm Description
HHT patients with a dilated or tortuous hepatic artery and a normal cardiac index
Intervention Type
Other
Intervention Name(s)
Stress echocardiography
Intervention Description
After a rest trans thoracic echocardiography (usual follow-up), eligible patients will have a stress ultrasound echocardiography on a dedicated cycle ergometer
Primary Outcome Measure Information:
Title
Comparison of exercise pulmonary artery systolic pressure in patients with HHT and liver involvement.
Description
The systolic pulmonary artery pressure (PAPS) during exercise will be compared between the two groups of patients. PAPS will be estimated by the maximum velocity (Vmax) of tricuspid insufficiency flow at peak exercise on cardiac ultrasound.
Time Frame
Day 1

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: HHT patient > 18 yo Hepatic involvement (hepatic artery diameter > 6mm) Patient having received the information and signed the informed consent form Patient affiliated to a social security scheme or beneficiaries of a similar scheme Exclusion Criteria: Haemoglobin < 90 g/L Active Infection Atrial Fibrillation permanent or persistent Known cardiopathy Pregnant or breastfeeding woman (by questioning) Adult subject to a legal protection measure (guardianship) Participation in another clinical trial that may interfere with the proposed trial (investigator judgment) Patient physically unable to pedal Patient with Pulmonary arteriovenous malformations awaiting embolization Patient treated with beta-blockers Secondary Exclusion Criteria verified on rest ultrasound PAH (Pulmonary Arterial Hypertension) at rest (Vmax > 2.8 m/sec) Inability to obtain a stream of IT at rest Patient with atrial fibrillation (AF)
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Cyrille BERGEROT, Dr
Phone
04 72 11 93 61
Ext
+33
Email
cyrille.bergerot@chu-lyon.fr
First Name & Middle Initial & Last Name or Official Title & Degree
Sophie DUPUIS-GIROD, Dr
Phone
04 27 85 65 25
Ext
+33
Email
sophie.dupuis-girod@chu-lyon.fr
Facility Information:
Facility Name
Service Explorations fonctionnelles cardiovasculaires - Hôpital Louis Pradel
City
Bron
ZIP/Postal Code
69677
Country
France
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Cyrille BERGEROT, Dr
Phone
04 72 11 93 61
Ext
+33
Email
cyrille.bergerot@chu-lyon.fr
First Name & Middle Initial & Last Name & Degree
Helène THIBAULT, Dr
Phone
04 72 35 69 07
Ext
+33
Email
helene.thibault@chu-lyon.fr
First Name & Middle Initial & Last Name & Degree
Cyrille BERGEROT, Dr
First Name & Middle Initial & Last Name & Degree
Helène THIBAULT, Dr
Facility Name
Service génétique - Hôpital Femme Mère Enfant
City
Bron
ZIP/Postal Code
69677
Country
France
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Sophie DUPUIS-GIROD, Dr
Phone
04 27 85 65 25
Ext
+33
Email
sophie.dupuis-girod@chu-lyon.fr
First Name & Middle Initial & Last Name & Degree
Sophie DUPUIS-GIROD, Dr
First Name & Middle Initial & Last Name & Degree
Alexandre GUILHEM, Dr

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Stress-Echography in Hereditary Haemorrhagic Telangiectasia Patient With Hepatic Involvement

We'll reach out to this number within 24 hrs